Rapid Test for Hemoglobin Provided by New Hand-Held Diagnostic Analyzer
|
By LabMedica International staff writers Posted on 26 Jun 2013 |
|
Image: The STAT-Site M Hgb hand-held hemoglobin analyzer from EKF Diagnostics (Photo courtesy of EKF Diagnostics).
A new hand-held analyzer has been developed to provide a simple and reliable point-of-care blood test for hemoglobin, enabling rapid diagnosis of conditions such as anemia.
EKF Diagnostics (Cardiff, UK) has introduced its “STAT-Site M Hgb” hand-held hemoglobin analyzer at the 2013 International Society of Blood Transfusion (ISBT) meeting. The STAT-Site M Hgb incorporates a new strip-based test for hemoglobin into a new, mobile analyzer, combining low cost per test with portability. This efficient analyzer is a maintenance-free, pocket-sized device that reliably delivers accurate hemoglobin analysis results within 30 seconds from 15 µL of finger-prick whole blood. Intuitive, step by step on-screen instructions minimize training and help maintain ease of use.
Due to its durability, portability, and user-friendliness, the STAT-Site M Hgb hemoglobin photometer is especially suited to developing world blood screening programs as well as for other settings where users are mobile. With an operating temperature range of 16-35 °C, the analyzer is also well suited for field use. Only one 3V Li type battery is required per 1,000 tests.
At ISBT, EKF also demonstrated its “Hemo Control” (“HemoPoint H2” in USA and Asia) hemoglobin analyzer designed to provide quantitative, lab quality results (imprecision < 2%) within 25 seconds for blood banks, hospitals, and clinics. From one simple test this portable and robust analyzer delivers results for both hemoglobin and hematocrit and, new for 2013, includes “Hemo Control Light” preloaded data management software that enables users to connect directly to hospital and laboratory information systems. Hemo Control uses the unique, patented “NXT” microcuvette technology, enabling precise and simple blood collection while reducing the risk of air bubble formation in blood samples, thereby also reducing inconvenience, waste, and cost.
Related Links:
EKF Diagnostics
EKF Diagnostics (Cardiff, UK) has introduced its “STAT-Site M Hgb” hand-held hemoglobin analyzer at the 2013 International Society of Blood Transfusion (ISBT) meeting. The STAT-Site M Hgb incorporates a new strip-based test for hemoglobin into a new, mobile analyzer, combining low cost per test with portability. This efficient analyzer is a maintenance-free, pocket-sized device that reliably delivers accurate hemoglobin analysis results within 30 seconds from 15 µL of finger-prick whole blood. Intuitive, step by step on-screen instructions minimize training and help maintain ease of use.
Due to its durability, portability, and user-friendliness, the STAT-Site M Hgb hemoglobin photometer is especially suited to developing world blood screening programs as well as for other settings where users are mobile. With an operating temperature range of 16-35 °C, the analyzer is also well suited for field use. Only one 3V Li type battery is required per 1,000 tests.
At ISBT, EKF also demonstrated its “Hemo Control” (“HemoPoint H2” in USA and Asia) hemoglobin analyzer designed to provide quantitative, lab quality results (imprecision < 2%) within 25 seconds for blood banks, hospitals, and clinics. From one simple test this portable and robust analyzer delivers results for both hemoglobin and hematocrit and, new for 2013, includes “Hemo Control Light” preloaded data management software that enables users to connect directly to hospital and laboratory information systems. Hemo Control uses the unique, patented “NXT” microcuvette technology, enabling precise and simple blood collection while reducing the risk of air bubble formation in blood samples, thereby also reducing inconvenience, waste, and cost.
Related Links:
EKF Diagnostics
Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
New
Saliva Collection & Stabilization Device
Salicomb/Saliswab
New
TRAb Immunoassay
Chorus TRAb
Latest Technology News
- Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
- Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
- Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
- Smartphones Could Diagnose Diseases Using Infrared Scans
- Novel Sensor Technology to Enable Early Diagnoses of Metabolic and Cardiovascular Disorders
- 3D Printing Breakthrough Enables Large Scale Development of Tiny Microfluidic Devices
- POC Paper-Based Sensor Platform to Transform Cardiac Diagnostics
- Study Explores Impact of POC Testing on Future of Diagnostics
- Low-Cost, Fast Response Sensor Enables Early and Accurate Detection of Lung Cancer
- Nanotechnology For Cervical Cancer Diagnosis Could Replace Invasive Pap Smears
- Lab-On-Chip Platform to Expedite Cancer Diagnoses
- Biosensing Platform Simultaneously Detects Vitamin C and SARS-CoV-2
- New Lens Method Analyzes Tears for Early Disease Detection
- FET-Based Sensors Pave Way for Portable Diagnostic Devices Capable of Detecting Multiple Diseases
- Paper-Based Biosensor System to Detect Glucose Using Sweat Could Revolutionize Diabetes Management
- First AI-Powered Blood Test Identifies Patients in Earliest Stage of Breast Cancer
Channels
Clinical Chemistry
view channel
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read more
Molecular Diagnostics
view channel
Blood Test Could Predict Relapse of Autoimmune Blood Vessel Disease
Neutrophils, once believed to be uniform in nature, have been discovered to exhibit significant diversity. These immune cells, which play a crucial role in fighting infections, are also implicated in autoimmune... Read more
First-of-its-Kind Blood Test Detects Trauma-Related Diseases
In today’s fast-paced world, stress and trauma have unfortunately become common experiences for many individuals. Continuous exposure to stress hormones can confuse the immune system, causing it to misinterpret... Read more
Hematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read more
Immunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read more
Microbiology
view channel
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Pathology
view channel
Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation
Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more
World’s First AI Model for Thyroid Cancer Diagnosis Achieves Over 90% Accuracy
Thyroid cancer is one of the most common cancers worldwide, and its precise management typically relies on two primary systems: (1) the 8th edition of the American Joint Committee on Cancer (AJCC) or ... Read more
Breakthrough Diagnostic Approach to Significantly Improve TB Detection
Tuberculosis (TB) remains the deadliest infectious disease globally, with 10.8 million new cases and 1.25 million deaths reported in 2023. Early detection through effective screening is crucial in identifying... Read more
Rapid, Ultra-Sensitive, PCR-Free Detection Method Makes Genetic Analysis More Accessible
Genetic testing has been an important method for detecting infectious diseases, diagnosing early-stage cancer, ensuring food safety, and analyzing environmental DNA. For a long time, polymerase chain reaction... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more
